Pharmaceuticals Sector — PSX Analysis
The pharmaceutical sector manufactures and distributes medicines and healthcare products in Pakistan. Companies range from multinationals with patented drugs to local manufacturers producing generic medicines.
At a Glance
- Companies tracked
- 7
- Valuation approach
- Cash-generative
- Reference P/E
- 12-18x
- Reference P/B
- 2-4x
- Reference dividend yield
- 2-4%
Reference ranges are SeekhKar editorial benchmarks for comparison, not live market figures. To check a company against them, use today's price from your broker and its latest reported EPS, book value and dividends. Models used: Two-stage DCF and P/E-relative.
Pharmaceuticals Stocks Compared
The listed companies side by side on their latest results: P/E, P/B, dividends, growth and debt.
GSK vs Abbott vs Highnoon vs Searle: Pharma Stocks 2026
GSK Pakistan, Abbott, Highnoon and Searle compared on P/E, P/B, ROE, dividend yield and 2026 profit growth. Which pharma stock is best value?
Updated 3 Nov 2026 · 6 min read
Haleon Pakistan vs AGP: Pharma Stocks 2026
Haleon Pakistan and AGP compared on P/E, P/B, ROE, dividend yield, debt and 2026 profit growth. Which of these two pharma stocks is better value?
Updated 3 Nov 2026 · 4 min read
Earnings Drivers
Drug pricing policy, new product launches, healthcare spending growth, export opportunities, and raw material costs.
Key Metrics to Watch
Gross margins, new product pipeline, API cost ratio, export revenue share, and market share by therapy area.
Investment Risks
Government drug price controls, API import dependency, currency devaluation raising input costs, and regulatory approvals for new products.
How to Value Companies in the Pharmaceuticals Sector
Cash-generative. Businesses with relatively steady free cash flow and assets that book value understates (brands, software, reserves). A DCF on free cash flow per share and P/E against the sector median suit them.
Two-stage DCF
Future free cash flow discounted back to today: suits companies whose cash flow is steady enough to forecast.
P/E-relative
EPS × the sector's typical P/E: what the company would be worth if the market priced it like its peers.
SeekhKar's own models assume a 18% required return for this sector. Use them as a starting point in the calculators and test higher and lower values. These are editorial assumptions, explained on the Methodology page.
Frequently Asked Questions
Calculators for This Sector
Run the methods that suit Pharmaceuticals companies with figures from their latest reports: